{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:27:51Z","timestamp":1790659671521,"version":"4.1.0"},"reference-count":19,"publisher":"Society for Clinical Epidemiology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACE","Ann Clin Epidemiol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.37737\/ace.22006","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T22:08:43Z","timestamp":1644358123000},"page":"41-48","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Dobutamine on Patients with Septic Shock: A Retrospective Nationwide Study"],"prefix":"10.37737","volume":"4","author":[{"given":"Shotaro","family":"Aso","sequence":"first","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24670","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 2017;45:486\u2013552. doi:10.1097\/CCM.0000000000002255","DOI":"10.1097\/CCM.0000000000002255"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801\u2013810. doi:10.1001\/jama.2016.0287","DOI":"10.1001\/jama.2016.0287"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ruffolo R. The pharmacology of dobutamine. Am J Med Sci 1987;294:244\u2013248.","DOI":"10.1097\/00000441-198710000-00005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580\u2013637. doi:10.1097\/CCM.0b013e31827e83af","DOI":"10.1097\/CCM.0b013e31827e83af"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Yealy DM, Kellum JA, Huang DT, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014;370:1683\u20131693. doi:10.1056\/NEJMoa1401602","DOI":"10.1056\/NEJMoa1401602"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Bailey M, Bellomo R, Peter A, et al. Goal-Directed Resuscitation for Patients with Early Septic Shock. N Engl J Med 2014;371:1946\u20131506. doi:10.1056\/NEJMoa1404380","DOI":"10.1056\/NEJMoa1404380"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015;372:1301\u20131311. doi:10.1056\/NEJMoa1500896","DOI":"10.1056\/NEJMoa1500896"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007;370:676\u2013684. doi:10.1016\/S0140-6736(07)61344-0","DOI":"10.1016\/S0140-6736(07)61344-0"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Gordon AC, Perkins GD, Singer M, et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016;375:1638\u20131648. doi:10.1056\/NEJMoa1609409","DOI":"10.1056\/NEJMoa1609409"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006;104:556\u2013569. doi:10.1097\/00000542-200603000-00024","DOI":"10.1097\/00000542-200603000-00024"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Yamana H, Moriwaki M, Horiguchi H, et al. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 2017;27:476\u2013482. doi:10.1016\/j.je.2016.09.009","DOI":"10.1016\/j.je.2016.09.009"},{"key":"12","unstructured":"12. Ohta T, Waga S, Handa H, et al. New grading of level of disordered consciousness (author\u2019s translation). No shinkei geka 1974;2:623\u2013627."},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome\u2014reintroduction of Japan Coma Scale: a cohort study. BMJ Open 2013;3:e002736. doi:10.1136\/","DOI":"10.1136\/bmjopen-2013-002736"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ono K, Wada K, Takahara T, et al. Indications for Computed Tomography in Patients With Mild Head Injury. Neurol Med Chir 2007;47:291\u2013298.","DOI":"10.2176\/nmc.47.291"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Quan H, Li B, Couris CM, et al. Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011;173:676\u2013682. doi:10.1093\/aje\/kwq433","DOI":"10.1093\/aje\/kwq433"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707\u2013710. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8844239","DOI":"10.1007\/BF01709751"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Xu S, Ross C, Raebel MA, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Heal 2010;13:273\u2013277. doi:10.1111\/j.1524-4733.2009.00671.x","DOI":"10.1111\/j.1524-4733.2009.00671.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Austin PC. Balance diagnostics for comparing the distribution of baselinecovariates between treatment groups in propensity-scorematched samples. Stat Med 2009;28:3083\u20133107. doi:10.1002\/sim","DOI":"10.1002\/sim.3697"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 2015;34:3661\u20133679. doi:10.1002\/sim.6607","DOI":"10.1002\/sim.6607"}],"container-title":["Annals of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ace\/4\/2\/4_22006\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T04:44:09Z","timestamp":1649479449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ace\/4\/2\/4_22006\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.37737\/ace.22006","relation":{"references":[{"id-type":"doi","id":"10.51023\/data.ace.19397009","asserted-by":"subject"}]},"ISSN":["2434-4338"],"issn-type":[{"value":"2434-4338","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22006"}}